Erin Mershon
Drugmakers accused of stalling biosimilars: FDA’s Gottlieb calls tactics ‘a toxin’
Food and Drug Administration Commissioner Scott Gottlieb on Wednesday [July 18] accused drug makers who manufacture pricey biologic medicines of ...
Biosimilar market creates rift in drug industry known for its solidarity
The pharmaceutical industry’s massive lobbying operation has a well-earned reputation for maintaining a united front on most of the major ...
